5Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature, 2001,414: 813-820.
6Du XL, Edelstein D, Dimmeler S, et al. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest,2001,108: 1341-1348.
7Du X,Matsumura T,Edelstein D,et al. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest, 2003, 112: 1049-1057.
8Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy.Lancet, 2000,355: 253-259.
9Stevens MJ, Obrosova I, Cao X, et al. Effects of DL-alpha-lipic acid on peripheral nerve conduction, blood flow, energy metablism, and oxidative stress in experimental diabetic neuropathy. Diabetes, 2000, 49: 1006-1015.
10Androne L, Gavan NA, Veresiu IA, et al. In vivo effect of lipoic acid on lipid peroxidation in patients with diabetic neuropathy. In Vivo, 2000,14: 327-330.
